Validation of optimal hormone levels in transgender women

Validation of optimal hormone levels in transgender women - Validation of optimal hormone levels in transgender women

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059982

Enrollment

Registered

2025-12-04

Start date

2025-07-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transgender women

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Transgender women undergoing gender-affirming hormone therapy

Exclusion criteria

Exclusion criteria: Transgender women who undergo gender-affiming surgery

Design outcomes

Primary

Measure	Time frame
Correlation between WHO-QOL assessment and hormone levels	—

Countries

Japan

Contacts

Public ContactTsuyoshi Baba

Sapporo Medical University Department of Obstetrics and Gynecology

tbaba@sapmed.ac.jp0116112111

Outcome results